AI assistant
RESMED INC — Director's Dealing 2013
May 15, 2013
30071_dirs_2013-05-15_cfc52bcc-3548-4393-85de-ae8d06f4a4f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-05-13
Reporting Person: QUINN MICHAEL A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-13 | ResMed Common Stock | S | 15000 | $50.942 | Disposed | 296000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Chess Depositary Instruments | 400000 | Direct |
| ResMed Chess Depositary Instruments | 306000 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $50.78 to $51.18. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
F2: These shares are held as CDIs on the Australian Securities Exchange which represents 24,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.
F3: These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.